Oncopro NCCN Lung Cancer Panel Test sale cost 23400 AED
Oncopro PD-L1 Circulating Tumor Cells Test sale cost 9880 AED Oncopro PD-L1 Circulating Tumor Cells Test 12,000 د.إ Original price was: 12,000 د.إ.9,880 د.إCurrent price is: 9,880 د.إ.
Sale!

Oncopro NCCN Lung Cancer Panel Test

Original price was: 26,000 د.إ.Current price is: 23,400 د.إ.

-10%

The Oncopro NCCN Lung Cancer Panel Test, available at DNA Labs UAE, is a cutting-edge diagnostic tool designed to aid in the personalized treatment of lung cancer. This comprehensive test, priced at 23,400 AED, employs next-generation sequencing technology to analyze a patient’s tumor sample for specific genetic mutations and biomarkers identified by the National Comprehensive Cancer Network (NCCN) guidelines as relevant to lung cancer care. By pinpointing these unique genetic alterations, the test enables healthcare providers to tailor treatment strategies to the individual patient, potentially improving outcomes and reducing the likelihood of unnecessary side effects. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant advancement in the precision medicine approach to lung cancer treatment, offering hope for more effective and personalized care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOPRO NCCN LUNG CANCER PANEL Test

Test Name: ONCOPRO NCCN LUNG CANCER PANEL Test

Test Components:

  • EGFR
  • ALK
  • ERBB2
  • BRAF
  • MET
  • RET
  • ROS1
  • NTRK1
  • KRAS
  • MSI

Price: 23400.0 AED

Sample Condition: 20 mL whole blood in 2 Streck tubes available from LPL. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32) is mandatory.

Report Delivery: Sample Daily by 9 am; Report 35 Working days

Method: Next Generation Sequencing

Test type: Cancer

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32) is mandatory.

Test Details

The ONCOPRO NCCN Lung Cancer Panel Test is a diagnostic test that analyzes a patient’s tumor tissue for specific genetic mutations and biomarkers associated with lung cancer. The test is based on the guidelines provided by the National Comprehensive Cancer Network (NCCN) and identifies mutations in genes such as EGFR, ALK, ROS1, BRAF, MET, RET, and NTRK. These mutations are important in predicting response to targeted therapies and can help guide treatment decisions.

The ONCOPRO NCCN Lung Cancer Panel Test is a non-invasive test that can be performed on a small tissue sample obtained through a biopsy or surgery. The results of the test are used by physicians to develop personalized treatment plans for patients with lung cancer.

Test Name ONCOPRO NCCN LUNG CANCER PANEL Test
Components *EGFR *ALK *ERBB2 *BRAF *MET *RET *ROS1 *NTRK1 *KRAS*MSI
Price 23400.0 AED
Sample Condition 20 mLwhole bloodin 2 Streck tubes available from LPL. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32)is mandatory.
Report Delivery Sample Daily by 9 am; Report 35 Working days
Method Next Generation Sequencing
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32)is mandatory.
Test Details

The ONCOPRO NCCN Lung Cancer Panel Test is a diagnostic test that analyzes a patient’s tumor tissue for specific genetic mutations and biomarkers associated with lung cancer. The test is based on the guidelines provided by the National Comprehensive Cancer Network (NCCN) and identifies mutations in genes such as EGFR, ALK, ROS1, BRAF, MET, RET, and NTRK. These mutations are important in predicting response to targeted therapies and can help guide treatment decisions. The ONCOPRO NCCN Lung Cancer Panel Test is a non-invasive test that can be performed on a small tissue sample obtained through a biopsy or surgery. The results of the test are used by physicians to develop personalized treatment plans for patients with lung cancer.

SKU: TEST-677 Category:

Related products